Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?
A Randomized, Double-Blind, Active Controlled Clinical Trial of Switching to Vilazodone for Antidepressant-Associated Sexual Dysfunction
Sponsor: Forest Laboratories
Terminated
PI left institution
Other terminated trials from Forest Laboratories
Other Major Depressive Disorder trials with similar outcome
This PHASE4 trial investigates Major Depressive Disorder and Sexual Dysfunction and is currently terminated or withdrawn. Forest Laboratories leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE4
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Forest Laboratories
- Thomas Jefferson University
For direct contact, visit the study record on ClinicalTrials.gov .